FDA panel votes to ease restrictions on an unregulated peptide BPC-157

A moment ago, an advisory committee for the FDA voted to ease restrictions on a popular but unregulated peptide. The group will vote today on the regulations surrounding a few other peptides as well. They've really surged in popularity across this wellness industry.Despite some doctors expressing their skepticism about the safety and efficacy of peptides, a few have actually gone undergone thorough clinical trials. Yet, some influencers and celebrities are still marketing them as effective treatments for a ...